
Aligned Bio
Aligned Bio's technology makes nanowire sensors cost-effective. The use of three patented technologies allows to improve biomarker detection platform devices by 20 times.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | €1.6m | Early VC | |
Total Funding | 000k |
EUR | 2020 | 2021 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
% EBITDA margin | (2474 %) | - |
Profit | 0000 | 0000 |
% profit margin | (2813 %) | - |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Developer of advanced nanowire-based biosensor system designed for the biosensor and electronics industries. The company's system offers nanowire platforms for diagnosing and treating diseases, identifying pathogens and pesticides, monitoring pollution, and other sensor-based applications, enabling sensor manufacturers to gain the benefits of the large area of nanowires and improved signal capacity at a low cost.
Keywords: Pharmaceuticals and Biotechnology, Biosensor Platform, Biosensor Platform Technology, Nanotechnology Company, Nanowire Platform, Nanowire Sensors, Nanowire Technology.